Ligand Pharmaceuticals
LGND
₹11,691
Share price
-0.67%
Change (1 day)
28.36%
Change (1 year)
EPS for Ligand Pharmaceuticals (LGND)
EPS in 2025 (TTM): -₹602.37
According to Ligand Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -₹616.94. In 2024 the company made an earnings per share (EPS) of -₹4.33 a decrease over its 2023 EPS that were of ₹250.42.
EPS history for Ligand Pharmaceuticals from 2012 to 2025
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2025 (TTM) | -₹602.37 | 13803.58% |
| 2024 | -₹4.33 | -101.73% |
| 2023 | ₹250.42 | -245.96% |
| 2022 | -₹171.57 | -157.23% |
| 2021 | ₹299.81 | -2571.43% |
| 2020 | -₹12.13 | -100.46% |
| 2019 | ₹2,652 | 353.48% |
| 2018 | ₹584.88 | 1025% |
| 2017 | ₹51.99 | -700% |
| 2016 | -₹8.66 | -100.87% |
| 2015 | ₹1,002 | 1859.32% |
| 2014 | ₹51.12 | 5.36% |
| 2013 | ₹48.52 | 8.0704505322479E+18% |
| 2012 | ₹0.0000000000 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | ₹957.47 | -255.20% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | -₹31.19 | -94.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | ₹135.15 | -121.91% | 🇬🇧 UK |
 Merck MRK | ₹597.65 | -196.87% | 🇺🇸 USA |
 Pfizer PFE | ₹120.44 | -119.52% | 🇺🇸 USA |
 Eli Lilly LLY | ₹1,071 | -273.54% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | ₹232.22 | -137.64% | 🇺🇸 USA |
 Baxter BAX | -₹2.60 | -99.58% | 🇺🇸 USA |
 Johnson & Johnson JNJ | ₹785.70 | -227.35% | 🇺🇸 USA |